The IC50 values and inhibition constants were further determined.
The optimum levels of these key variables were further determined using a central composite design.
The optimal levels of the three nitrogen sources were further determined through central composite experimental design.
Water vapour transmission rate and oxygen permeability of nanocomposites were further determined and obtained results have been correlated to the effect of interactions between the incorporated nanoparticles and water/oxygen molecules.
Non-steroidal anti-inflammatory drugs (NSAIDs), namely, ketoprofen, naproxen, diclofenac and ibuprofen, were selected as model analytes in a proof-of-concept design, and they were further determined by liquid chromatographic (LC) assays.
X-ray photoelectron spectroscopy (XPS) analysis revealed the removal of oxygen functionality from the GO surface after reduction and the bonding structure of the reduced composites were further determined from FTIR and Raman spectroscopic analysis.
The molecular structures of complex 2a and 2b were further determined by single crystal X-ray diffraction, both of them adopt a three-legged distorted tetrahedral geometry in which the aryl substituents are orthogonally to the aryloxide group.
The mice were treated with ABLS, the serum and tissues levels of NO, MDA, ET-1, VEGF, and CGRP were determined using the experimental kits, the mRNA levels of various genes in the heart muscle and blood vessel tissues were further determined by RT-PCR assay.
The mutagenesis efficiencies were further determined on the target-2.
The kinetic parameters were further determined from Lineweaver Burk plots.
The immunogenicity and anti-HBV activity were further determined in HBV and HLA-A2 transgenic mice.
